Burges Salmon advises Edinburgh biotech firm on £9m funding
![Burges Salmon advises Edinburgh biotech firm on £9m funding](https://www.scottishlegal.com/uploads/Katie%20Carter%20Temp%20Corporate%20Image%20Web%20Profile.jpg)
Katie Carter
Burges Salmon has advised cancer therapeutics company Cumulus Oncology Limited on the £9 million funding package it secured from the Scottish National Investment Bank and Eos Advisory.
An Edinburgh-based team from Burges Salmon’s corporate and M&A team advised Cumulus Oncology, led by senior associate Katie Carter, partner Danny Lee, associate Victoria MacAulay and solicitor Scott Patterson.
Ms Carter said: “Cumulus Oncology is a fantastic company that drives scientific innovation and de-risks science. We’ve been working with Cumulus Oncology since 2020 and it has been a pleasure to advise the team on this significant financing which supports the development of cancer research and shines a light on Scotland’s flourishing biotech capabilities.”